脾脏体积测定与肝脏瞬时弹性成像预测肝细胞癌肝切除术后持续性肝功能失代偿
多因素分析显示肝脏硬度测量和脾脏体积测定均为肝切除术后肝功能失代偿的独立预测因素,且脾脏体积测定可提高预测敏感性(从62%升至97%)和阴性预测值(从96%升至100%)。
要点
- 肝脏硬度测量>11.6 kPa和脾脏体积>381.1 cm³可独立预测肝切除术后肝功能失代偿。
- 联合脾脏体积测定可将预测敏感性从62%提高至97%,阴性预测值从96%提高至100%。
- 脾脏体积>380 cm³和肝脏硬度>12 kPa是非侵入性、协同的预测工具。
核心结论
- 脾脏体积测定(>380 cm³)和肝脏硬度测量(>12 kPa)是非侵入性、独立且协同的工具,能够预测肝切除术后肝功能失代偿。
主要发现
- 术后90天死亡率为4.7%。
- 多因素分析显示肝脏硬度测量和脾脏体积测定均预测肝切除术后肝功能失代偿。
- 肝脏硬度测量截断值11.6 kPa(AUC=0.71,95%CI 0.71-0.88,敏感性89%,特异性47%)。
- 脾脏体积测定截断值381.1 cm³(AUC=0.78,95%CI 0.77-0.93,敏感性55%,特异性91%)。
关键数值与推荐
- 肝脏硬度测量截断值11.6 kPa,脾脏体积测定截断值381.1 cm³。
- 结论中推荐脾脏体积>380 cm³和肝脏硬度>12 kPa作为预测工具。
临床怎么用
- 对于肝细胞癌拟行肝切除的患者,可考虑术前使用肝脏瞬时弹性成像和脾脏体积测定来识别肝功能失代偿高风险者。
- 联合脾脏体积测定可提高排除失代偿的阴性预测值,有助于筛选适合切除的患者或考虑替代治疗。
局限性
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Posthepatectomy decompensation remains a frequent and poor outcome after hepatectomy, but its prediction is still inaccurate. Liver stiffness measurement can predict posthepatectomy decompensation, but there is a so-called "gray zone" that requires another predictor. Because splenomegaly is an objective sign of portal hypertension, we hypothesized that spleen volumetry could improve the identification of patients at risk. METHODS: Patients with hepatocellular carcinoma who underwent hepatectomy in our tertiary center between August 2014 and December 2017 were reviewed. The primary endpoint was to determine if the spleen volumetry and liver stiffness measurement were independent predictors of posthepatectomy decompensation, and secondarily, to determine if they were synergistic through a theoretic predictive model. RESULTS: One hundred and seven patients were included. The median follow-up time was 3 months (3-5). Postoperative 90-day mortality was 4.7%. By multivariate analysis, liver stiffness measurement and spleen volumetry predicted posthepatectomy decompensation. The liver stiffness measurement had a cutoff point of 11.6 kPa (area under receiver operating curve = 0.71 confidence interval 95% 0.71-0.88, sensitivity: 89%, specificity: 47%). The spleen volumetry cutoff point was 381.1 cm3 (area under receiver operating curve = 0.78, 95% confidence interval 0.77-0.93, sensitivity: 55%, specificity: 91%). The spleen volumetry improved prediction of posthepatectomy decompensation, because use of the spleen volumetry increased sensitivity (from 62% to 97%) and the negative predictive value (from 96% to 100%) along with a negligible decrease in specificity (from 96.7 to 93.4) and positive predictive value (from 64% to 59%) (P = .003). CONCLUSION: Spleen volumetry (>380 cm3) and liver stiffness measurement (>12 kPa) are non-invasive, independent, and synergistic tools that appear to be able to predict posthepatectomy decompensation. The importance of this finding is that these measurements may help to anticipate posthepatectomy decompensation and may possibly be used to direct alternative treatments to resection.
引用
- Fernández-Placencia R, Golse N, Cano L, et al. Spleen volumetry and liver transient elastography: Predictors of persistent posthepatectomy decompensation in patients with hepatocellular carcinoma. Surgery. 2020. PMID: 32204923. doi:10.1016/j.surg.2020.02.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。